Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124828302 | 12482830 | 2 | F | 20160520 | 20160915 | 20160620 | 20160927 | PER | US-ACTELION-A-US2016-136883 | ACTELION | 61.00 | YR | A | F | Y | 0.00000 | 20160927 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124828302 | 12482830 | 1 | PS | OPSUMIT | MACITENTAN | 1 | Oral | 10 MG, QD | 204410 | 10 | MG | TABLET | QD | ||||||
| 124828302 | 12482830 | 2 | SS | INDERAL | PROPRANOLOL HYDROCHLORIDE | 1 | Unknown | U | U | 0 | |||||||||
| 124828302 | 12482830 | 3 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 4 | C | SPS | SODIUM POLYSTYRENE SULFONATE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 5 | C | WARFARIN | WARFARIN | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 6 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 7 | C | RENVELA | SEVELAMER CARBONATE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 9 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 10 | C | ONDANSETRON | ONDANSETRON | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 11 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 12 | C | HYDROMORPHONE | HYDROMORPHONE | 1 | U | 0 | |||||||||||
| 124828302 | 12482830 | 13 | C | DOCUSATE SODIUM. | DOCUSATE SODIUM | 1 | 100 MG, BID | U | 0 | 100 | MG | BID | |||||||
| 124828302 | 12482830 | 14 | C | SENNOSIDES A+B | SENNOSIDES A AND B | 1 | 8.6 MG, BID | U | 0 | 8.6 | MG | BID | |||||||
| 124828302 | 12482830 | 15 | C | SUCRALFATE. | SUCRALFATE | 1 | 1 GR, QID | U | 0 | QID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124828302 | 12482830 | 1 | Pulmonary arterial hypertension |
| 124828302 | 12482830 | 2 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124828302 | 12482830 | Blood pressure systolic decreased | |
| 124828302 | 12482830 | Condition aggravated | |
| 124828302 | 12482830 | Dyspnoea | |
| 124828302 | 12482830 | Migraine | |
| 124828302 | 12482830 | Muscular weakness | |
| 124828302 | 12482830 | Pain in extremity | |
| 124828302 | 12482830 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124828302 | 12482830 | 1 | 201412 | 0 |